HomeAI · summaries
Storia in 2 fonti
These Analysts Slash Their Forecasts On Insulet After Q2 Results - Insulet (NASDAQ:PODD)
Insulet Corp. (NASDAQ:PODD) reported strong Q2 earnings but lowered revenue outlook for 2021. Analysts downgraded stock and lowered price targets.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Why Is Insulet Stock Sinking Wednesday? - Insulet (NASDAQ:PODD)
Insulet (PODD) stock falls despite beating Q2 earnings as the company lowers its full-year 2026 revenue guidance. Get details here.
- ·
investors.com
Why Investors Took A Hammer To These Two Medical Stocks
Insulet stock crashed Wednesday after lowering sales guidance for its body-worn insulin pump in the back half of the year.
